WENTWORTH KORY JAMES (Chief Financial Officer) reported 1 transaction at ENTRADA THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 9/4/2025ACC: 0001725663-25-000003
Officer· Chief Financial Officer
Since Oct 2021
-1.73K
Net shares
Net seller
$9.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
1.73K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.73K
Price / share
$5.43
Trade value
$9.42K
% of position
1.4%
9/2/2025
120.67K→118.94K
Total
Net shares
−1.73K
Net value
-$9.42K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2025 | F · Tax Withholding | −1.73K | $5.43 | $9.42K | 1.4% | 120.67K | 118.94K |
| Total | −1.73K | -$9.42K | ||||||
Derivative Transactions0
No derivative transactions reported